Epic Sciences (San Diego, CA), a preclinical-stage biotechnology company focused on cancer diagnostics, closed a $13M Series B financing. Participants include Domain Associates, Roche Venture Fund, and Pfizer Venture Investments.

Collective IP | The World’s Largest Technology Transfer Office Marketplace

Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets

Receive Collective IP Account Access HERE